Pharmacological Targeting of the Actin Cytoskeleton to Drive Endocrinogenesis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
In vitro generation of insulin-secreting beta cells from human pluripotent stem cells (hPSCs) opens new avenues for treating and modeling diabetes. Hogrebe and colleaguesestablished a new 2D differentiation protocol where they targeted the cytoskeleton pharmacologically for controlled endocrine induction and generation of hPSC-derived beta cells with improved function.
Citing Articles
Talwar P, Kushwaha S, Rawat C, Kaur H, Srivastava A, Agarwal R Front Genet. 2021; 12:722221.
PMID: 34956307 PMC: 8696000. DOI: 10.3389/fgene.2021.722221.